Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules is a specialized formulation developed by Bayview Pharmacy. This unique blend combines two potent active ingredients, belladonna alkaloids and phenobarbital, to provide long-lasting relief from a range of disease states. These conditions include anxiety, insomnia, seizures, and muscle spasms. The slow-release capsule, formulated with Methocel E4M, a type of controlled-release polymer, ensures that the active ingredients are gradually released over an extended period. This gradual release offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.

For healthcare providers, this formulation presents a safe and effective treatment option for a variety of conditions. The combination of belladonna alkaloids and phenobarbital offers a potent and effective treatment that is generally well-tolerated by most patients. The slow-release capsule ensures that the active ingredients are gradually released over time, providing sustained relief. This formulation is an excellent choice for patients who require long-term relief from their symptoms.

At Bayview Pharmacy, we take pride in offering this unique formulation to our patients and healthcare providers. If you have any questions about this formulation or any of our other products, please do not hesitate to contact us. We are here to assist you.

Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules are a compounded formulation designed for controlled and prolonged release. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the encapsulated medication over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled release profile.

It's important to note that Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules may interact with other medications, including but not limited to anticholinergics, anticonvulsants, sedatives, and other CNS depressants. Therefore, patients are advised to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. This is to ensure the prevention of potential drug-drug interactions.

Furthermore, patients should also be aware of potential drug-disease interactions. Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules may interact with certain medical conditions, such as glaucoma, asthma, and urinary retention. Therefore, patients should inform their healthcare provider of any existing medical conditions before starting this medication.

Patients are strongly advised not to take Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules if they are currently on any of the following medications: anticholinergics, anticonvulsants, sedatives, or other CNS depressants. Additionally, patients should avoid alcohol while taking this medication to prevent potential adverse effects.

If you have any questions or concerns about the potential interactions of Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules, please consult with your healthcare provider for further information and guidance.

Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules are a compounded formulation of two potent medications, designed to treat a variety of conditions. The belladonna alkaloids are anticholinergic agents that function by inhibiting the action of acetylcholine, a neurotransmitter that plays a crucial role in muscle contractions. On the other hand, phenobarbital is a barbiturate that operates by depressing the central nervous system. The combined effect of these two medications makes this formulation effective in managing conditions such as seizures, anxiety, and insomnia.

The unique feature of these capsules is their slow-release mechanism, facilitated by the use of Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only ensures a consistent and prolonged effect but also reduces the frequency of dosing, thereby improving patient compliance, particularly for medications that necessitate a controlled and extended release profile.

These capsules are intended for oral administration and should be taken with a full glass of water. It is crucial to adhere to the prescribed dosage and not to take more or less than the recommended amount. It's worth noting that Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules may induce drowsiness or dizziness. Therefore, activities requiring alertness, such as driving or operating machinery, should be avoided until you are aware of how the medication affects you. Additionally, alcohol consumption should be avoided while on this medication.

If you have any queries or concerns about Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules, do not hesitate to seek professional advice. It's important to understand how this medication works and how it can assist in managing your condition.

Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules are a compounded formulation designed to provide sustained therapeutic effects over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer that gradually releases the encapsulated medication or active ingredient. This formulation is primarily used to treat conditions such as spasticity, muscle spasms, certain types of pain, and specific types of seizures, including absence seizures. It can also be beneficial in reducing the frequency of seizures in patients with Lennox-Gastaut syndrome.

Furthermore, this formulation may be used to alleviate the severity of withdrawal symptoms in patients who are trying to stop using alcohol or other drugs. However, it is crucial to note that this formulation should not be used to treat any condition other than those specifically listed without first consulting a physician. It is also important to be aware that this formulation may cause side effects such as drowsiness, dizziness, and confusion, and should not be used while operating a motor vehicle or machinery.

If you have any questions or concerns about the use of Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules, it is recommended that you seek advice from a healthcare professional. Remember, patient safety and effective treatment are of utmost importance.